Corvia Medical, Inc. filed a Form D with the Securities and Exchange Commission on 2025-06-25.
Corvia Medical, Inc. filed a Form D notice of an exempt securities offering with the SEC on June 25, 2025. The filing reports $8.86M sold. Its industry group is Biotechnology. It names George Fazio (Executive Officer, Director), Gerald Brunk (Director), David Celermajer (Director) (SEC Form D, June 25, 2025).
Is this your company?
Sell to companies like Corvia Medical, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-06-25 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Corvia Medical, Inc.
Free to see. No signup.
More on the people and the money behind Corvia Medical, Inc., from the filings we hold.
Biotechnology raises by companies based in Massachusetts, filed in June 2025, largest first.
Get an email when Corvia Medical, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Corvia Medical, Inc. raises, hires or launches. No email unless you switch it on.
Watch Corvia Medical, Inc. →Get the full cited report on Corvia Medical, Inc.
What the filing shows about Corvia Medical, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Corvia Medical, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Corvia Medical, Inc.'s address as 1 Highwood Drive, Suite 300, Tewksbury, MA 01876.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Corvia Medical, Inc. is a registered filer with the SEC (CIK 1464449) and has filed since 2025-06-25. 1 filing is on record, the latest on 2025-06-25.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Corvia Medical, Inc.'s Form D of 2025-06-25 names George Fazio, Gerald Brunk, David Celermajer and 4 more as its officers, directors or promoters.
Its new offerings report $8.86M sold across 1 offering, as its own filings state.
Trailing twelve months. 769 filings in Biotechnology, totalled by week.
George Fazio is named as Executive Officer and Director on the Form D that Corvia Medical, Inc. filed with the SEC on 25 June 2025, one of 7 people that filing names.
Gerald Brunk is named as Director on the Form D that Corvia Medical, Inc. filed with the SEC on 25 June 2025, one of 7 people that filing names.
David Celermajer is named as Director on the Form D that Corvia Medical, Inc. filed with the SEC on 25 June 2025, one of 7 people that filing names.
Paul LaViolette is named as Director on the Form D that Corvia Medical, Inc. filed with the SEC on 25 June 2025, one of 7 people that filing names.
Irit Yaniv is named as Director on the Form D that Corvia Medical, Inc. filed with the SEC on 25 June 2025, one of 7 people that filing names.
Kevin Gillis is named as Director on the Form D that Corvia Medical, Inc. filed with the SEC on 25 June 2025, one of 7 people that filing names.
Dan Curtis is named as Executive Officer on the Form D that Corvia Medical, Inc. filed with the SEC on 25 June 2025, one of 7 people that filing names.
7 people named on the filing — 2 holding an executive role and 5 as directors only.
Named as of the 2025-06-25 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Corvia Medical, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Corvia Medical, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Corvia Medical, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Corvia Medical, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Corvia Medical, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Corvia Medical, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/corvia-medical-inc-form-d-25000001